甲亢患儿骨代谢及氧化应激状态的变化观察

来源 :实用预防医学 | 被引量 : 0次 | 上传用户:liuzixing0210
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的了解甲亢患儿骨代谢及氧化应激状态的变化情况。方法选取2013年10月-2016年3月期间宁波市妇女儿童医院诊断与治疗的75例甲亢患儿为观察组,同时选取同时间段期间的75名同龄健康儿童为对照组,分析比较两组儿童的血清骨代谢及氧化应激状态指标表达水平,并将观察组中不同基础代谢率及分型甲亢患儿的血清骨代谢及氧化应激状态指标表达水平进行比较。结果观察组的血清骨代谢指标BGP、ALP、PICP及ICTP分别为(13.28±1.51)μg/L、(142.68±13.96)U/L、(105.87±11.32)μg/L及(10.12±1.53)μg/L,均高于对照组的(7.57±0.82)μg/L、(101.54±9.76)U/L、(3.13±0.25)μg/L及(2.96±0.33)μg/L,血清氧化应激状态指标SOD、CAT、GSH-Px、Vit C、Vit E及MT分别为(65.24±5.20)n U/ml、(40.10±3.84)n U/ml、(73.63±7.07)U/L、(36.46±4.80)μg/ml、(7.10±0.89)μg/ml及(16.12±2.10)ng/L,均低于对照组的(82.52±6.43)n U/ml、(45.36±4.67)n U/ml、(84.98±8.15)U/L、(45.58±5.31)μg/ml、(10.26±1.57)μg/ml及(27.91±3.25)ng/L。观察组中不同基础代谢率甲亢患儿的血清骨代谢及氧化应激状态指标表达水平差异亦有统计学意义(均P<0.05),但不同分型儿童的血清骨代谢及氧化应激状态指标表达水平差异无统计学意义(均P>0.05)。结论甲亢患儿骨代谢及氧化应激状态呈现明显异常的状态,且不同基础代谢率甲亢患儿的表达水平也存在明显差异,因此应重视对此类患儿上述方面的监测与干预。 Objective To investigate the changes of bone metabolism and oxidative stress in children with hyperthyroidism. Methods 75 hyperthyroidism patients diagnosed and treated in Ningbo Women and Children’s Hospital from October 2013 to March 2016 were selected as the observation group and 75 healthy children of same age during the same period were selected as the control group. Children with serum bone metabolism and oxidative stress status indicators, and the observation group with different basal metabolic rate and type Hyperthyroidism serum bone metabolism and oxidative stress status indicators were compared. Results The serum BGP, ALP, PICP and ICTP of the observation group were (13.28 ± 1.51) μg / L, (142.68 ± 13.96) U / L, (105.87 ± 11.32) μg / L and (10.12 ± 1.53) μg / L were significantly higher than those in the control group (7.57 ± 0.82 μg / L, (101.54 ± 9.76) U / L, (3.13 ± 0.25) μg / L and (2.96 ± 0.33) μg / The indexes of SOD, CAT, GSH-Px, Vit C, Vit E and MT were (65.24 ± 5.20) nU / ml, (40.10 ± 3.84) nU / ml and (73.63 ± 7.07) U / 4.80 μg / ml, 7.10 ± 0.89 μg / ml and 16.12 ± 2.10 ng / L, respectively, which were all lower than those in the control group (82.52 ± 6.43) n U / ml and (45.36 ± 4.67) (84.98 ± 8.15) U / L, (45.58 ± 5.31) μg / ml, (10.26 ± 1.57) μg / ml and (27.91 ± 3.25) ng / L respectively. In the observation group, there were also significant differences in serum bone metabolism and oxidative stress status among hyperthyroidism patients with different basal metabolic rate (all P <0.05), but serum bone metabolism and oxidative stress index There was no significant difference in expression level (all P> 0.05). Conclusion The bone metabolism and oxidative stress status of hyperthyroidism patients showed obvious abnormal state, and the expression levels of hyperthyroidism patients with different basal metabolic rate also had significant differences. Therefore, we should pay attention to the monitoring and intervention of these aspects.
其他文献
目的 研究人参辅酶Q10复配制剂增强免疫力的作用. 方法 以0.083、0.167、0.500g/(kg·bw)低、中、高3个剂量,给小鼠连续灌胃30 d后,观察小鼠免疫器官脏器/体重比值、细胞免疫
目的 观察地佐辛配伍罗哌卡因用于妇科患者手术后镇痛的安全性和有效性.方法 择期行子宫与附件切除术患者50例,随机分为试验组和对照组,每组25例,均采用连续硬膜外麻醉.试验
目的 探讨膝关节镜辅助在膝关节周围骨折微创治疗中的应用价值.方法 选择2013年8月-2018年10月间该院收治的50例膝关节周围骨折患者为研究对象,根据治疗方法的不同分组,各组2
目的 评价小剂量氯胺酮对舒芬太尼皮下镇痛效果的影响.方法 行腰椎内固定术患者200例,随机分为4组:对照组(SF组)和试验组(SK1、SK2、SK3组).术毕即刻分别持续皮下输注舒芬太
供体胰腺切取,多数采用腹腔多器官联合切取技术。所以,胰腺修整前,需将胰腺自肝脏及双肾分离。在分离胰腺前,应认真检查供体胰腺灌注状况及有无损伤。如有严重损伤,应果断放弃胰腺
目的 观察星状神经节联合面神经阻滞治疗特发性面神经麻痹的疗效.方法 选择特发性面神经麻痹患者100例,采用星状神经节、面神经联合阻滞,同时配合药物口服治疗.根据患者治疗
目的 探讨右美托咪定在宫颈癌合并下肢骨折患者中的麻醉效果及安全性.方法 选择2016年5月-2018年5月治疗的宫颈癌合并下肢骨折患者82例作为对象,随机数字表分为对照组(n=41)
期刊
目的 调查术后患者自控静脉镇痛(PCIA)和硬膜外镇痛(PCEA)的镇痛满意度并分析其影响因素.方法 选取手术患者98例,随机接受PCIA和PCEA,记录患者的镇痛满意度、VAS评分,并记录
某患者,57岁,3个多月前因肾病综合征曾在本科住院治疗,肾穿刺活检病理诊断为原发性膜性肾病,给予糖皮质激素(美卓乐)加环磷酰胺治疗,出院后定期复诊。再次开药时患者说,“激素少开点